115 related articles for article (PubMed ID: 34355768)
21. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
[TBL] [Abstract][Full Text] [Related]
22. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
[TBL] [Abstract][Full Text] [Related]
23. miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells.
Li H; Li Y; Liu D; Sun H; Liu J
Cell Physiol Biochem; 2013; 32(2):448-58. PubMed ID: 23988648
[TBL] [Abstract][Full Text] [Related]
24. Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition.
Zhu XL; Wang YL; Chen JP; Duan LL; Cong PF; Qu YC; Li-Ling J; Zhang MX
Tumour Biol; 2014 Feb; 35(2):1627-35. PubMed ID: 24078466
[TBL] [Abstract][Full Text] [Related]
25. BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.
Han P; Fu Y; Luo M; He J; Liu J; Liao J; Tian D; Yan W
Dig Dis Sci; 2014 May; 59(5):992-1000. PubMed ID: 24442236
[TBL] [Abstract][Full Text] [Related]
26. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
[TBL] [Abstract][Full Text] [Related]
27. All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro.
Cui J; Gong M; He Y; Li Q; He T; Bi Y
Int J Oncol; 2016 Jan; 48(1):349-57. PubMed ID: 26548461
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
29. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
Hou H; Ge C; Sun H; Li H; Li J; Tian H
Cancer Sci; 2018 Apr; 109(4):1088-1100. PubMed ID: 29377347
[TBL] [Abstract][Full Text] [Related]
30. PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK/mTOR/ULK1 signaling pathway.
Zhang J; Wang E; Zhang L; Zhou B
Cell Biol Int; 2021 Feb; 45(2):305-319. PubMed ID: 33079432
[TBL] [Abstract][Full Text] [Related]
31. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC
Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449
[TBL] [Abstract][Full Text] [Related]
32. 3,3'-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis.
Munakarmi S; Shrestha J; Shin HB; Lee GH; Jeong YJ
Cells; 2021 May; 10(5):. PubMed ID: 34066056
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
34. microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression.
Sun Y; Liu L; Xing W; Sun H
Cell Signal; 2021 Jul; 83():109982. PubMed ID: 33741494
[TBL] [Abstract][Full Text] [Related]
35. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
[TBL] [Abstract][Full Text] [Related]
36. LncRNA FUNDC2P4 down-regulation promotes epithelial-mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Zeng J; Cai X; Hao X; Huang F; He Z; Sun H; Lu Y; Lei J; Zeng W; Liu Y; Luo R
Int J Hyperthermia; 2018 Sep; 34(6):802-811. PubMed ID: 29295626
[TBL] [Abstract][Full Text] [Related]
37. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
38. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
[TBL] [Abstract][Full Text] [Related]
39. Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells.
Li T; Xu WS; Wu GS; Chen XP; Wang YT; Lu JJ
Asian Pac J Cancer Prev; 2014; 15(4):1745-9. PubMed ID: 24641402
[TBL] [Abstract][Full Text] [Related]
40. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells.
Lim WC; Kim H; Ko H
J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]